Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D04TPA
|
||||
| Former ID |
DIB019306
|
||||
| Drug Name |
compound 1a
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [532826] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C19H19N7O
|
||||
| InChI |
InChI=1S/C19H19N7O/c1-11-3-4-15(7-16(11)22-12(2)27)23-17-8-18(24-14-5-6-14)26-19(25-17)13(9-20)10-21-26/h3-4,7-8,10,14,24H,5-6H2,1-2H3,(H,22,27)(H,23,25)
|
||||
| InChIKey |
GDSQVLMYYCNAGP-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Casein kinase II, alpha chain | Target Info | Inhibitor | [532826] | |
| PIM-3 protein kinase | Target Info | Inhibitor | [532826] | ||
| dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3 | Target Info | Inhibitor | [532826] | ||
| homeodomain interacting protein kinase 2 | Target Info | Inhibitor | [532826] | ||
| NetPath Pathway | FSH Signaling Pathway | ||||
| Pathway Interaction Database | BCR signaling pathway | ||||
| Atypical NF-kappaB pathway | |||||
| DNA-PK pathway in nonhomologous end joining | |||||
| Presenilin action in Notch and Wnt signaling | |||||
| Role of Calcineurin-dependent NFAT signaling in lymphocytes | |||||
| E-cadherin signaling in the nascent adherens junction | |||||
| Lissencephaly gene (LIS1) in neuronal migration and development | |||||
| PDGFR-alpha signaling pathway | |||||
| Signaling mediated by p38-alpha and p38-beta | |||||
| Alpha-synuclein signaling | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.